Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 78, 2018 - Issue 3
Submit an article Journal homepage
579
Views
16
CrossRef citations to date
0
Altmetric
Original Article

A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XNTM analyzers in routine laboratory practice

Françoise SchillingerLaboratoire d’hématologie, Etablissement Français du Sang de Bourgogne/Franche-Comté, Besançon, France; Correspondence[email protected]
,
Elise SourdeauLaboratoire d‘hématologie, Assistance Publique-Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France;
,
Marouane BoubayaUnité de Recherche Clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France;
,
Lucile BaseggioLaboratoire d’hématologie, Centre Hospitalier Universitaire Lyon Sud, Pierre-Bénite, France;
,
Sylvain ClauserUnité de Recherche Clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France;
,
Edouard CornetLaboratoire d'hématologie, Centre Hospitalier Universitaire Côte de Nacre, Caen, France; ORCID Iconhttp://orcid.org/0000-0003-1667-3421
ORCID Icon,
Camille DebordLaboratoire d’hématologie, Centre Hospitalier Universitaire de Nantes, Nantes, France;
,
Jean-Pierre DefourLaboratoire d’hématologie, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgique;
,
Frédérique DuboisLaboratoire d’hématologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France;
,
Marion EveillardLaboratoire d’hématologie, Centre Hospitalier Universitaire de Nantes, Nantes, France;
,
Anne-Cécile GaloisyLaboratoire d’hématologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France;
,
Marie-Odile GeayUnité de Recherche Clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France;
,
François MullierLaboratoire d’hématologie, Université catholique de Louvain, CHU UCL Namur, Namur, Belgique;
,
Vanessa NivaggioniLaboratoire d'Hématologie, Hôpital de la Timone, Centre Hospitalier Universitaire de Marseille, Marseille, France;
,
Valérie SoenenLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Lille, Lille, France;
,
Pascal MorelEtablissement Français du Sang de Bourgogne/Franche-Comté, Besançon, France;
,
Francine Garnache-OttouLaboratoire d’hématologie, Etablissement Français du Sang de Bourgogne/Franche-Comté, Besançon, France;
,
Emily RonezLaboratoire d‘hématologie, Assistance Publique-Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France;
,
Valérie BardetLaboratoire d‘hématologie, Assistance Publique-Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France;
&
Eric DeconinckService d’hématologie clinique, Centre Hospitalier Universitaire de Besançon, Besançon, France, INSERM UMR 1098, Université de Franche-Comté, Besançon, France
 show all
Pages 159-164 | Received 02 Jul 2017, Accepted 27 Dec 2017, Published online: 08 Jan 2018

References

  • Maynadie M, Girodon F, Manivet-Janoray I, et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote-d’Or (Burgundy, France). Haematologica. 2011;96:55–61.
  • Guru Murthy GS, Dhakal I, Mehta P. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States. Leuk Lymphoma. 2017;58:1648–1654.
  • Dinmohamed AG, Van Norden Y, Visser O, et al. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands. Leuk Res. 2015;39:177–182.
  • Swerdlow SH, Campo E, Lee Harris N, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: WHO; 2008.
  • Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision of the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
  • McCullough KB, Patnaik MM. Chronic myelomonocytic leukemia: a genetic and clinical update. Curr Hematol Malig Rep. 2015;10:292–302.
  • Patnaik MM, Tefferi A. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia. Blood Cancer J. 2016;6:393.
  • Elena C, Galli A, Such E, et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016;128:1408–1417.
  • Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification and management. Am J Hematol. 2016;9:631–642.
  • Parikh SA, Tefferi A. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management. Am J Hematol. 2013;88:967–974.
  • Bacher U, Haferlach T, Schnittger S, et al. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukemia. Br J Haematol. 2011;153:149–167.
  • Cornet E, Mullier F, Despas N, et al. Evaluation and optimization of the extended information process unit (E-IPU) validation module integrating the Sysmex flag systems and the recommendations of the French-speaking cellular hematology group (GFHC). Scand J Clin Lab Inves. 2016;76:465–471.
  • Genevieve F, Galoisy AC, Mercier-Bataille D, et al. Revue du frottis sanguin au microscope. Feuillets De Biologie. 2014;LVI:317.
  • Miguel A, Orero M, Simon R, et al. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia. Lab Hematol. 2007;13:98–102.
  • Inaba T, Yuki Y, Yuasa S, et al. Clinical utility of the neutrophil distribution pattern obtained using the cell-dyn sapphire hematology analyzer for the diagnosis of myelodysplastic syndrome. Int J Hematol. 2011;94:169–177.
  • Le Roux G, Vlad A, Eclache V, et al. Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100TM. Int J Lab Hematol. 2010;32:237–243.
  • Boutault R, Tremblais S, De Oliveira Lopes M, Peterlin P, et al. Interest of the XN-10® analyzer to screen for myelodysplastic syndromes on complete blood count (CBC) especially with hemoglobin levels and Neut-WX. Blood. 2016;128:5518.
  • Shen Q, Ouyang J, Jabbour EJ, et al. Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response. Eur J Haematol. 2015;95:168–176.
  • Selimoglu-Buet D, Wagner-Ballon O, Saada V, et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood. 2015;125:3618–3626.
  • Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: focus on clinical practice. Mayo Clin Proc. 2016;91:259–272.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.